Condition
Indomethacin
Total Trials
4
Recruiting
1
Active
1
Completed
2
Success Rate
66.7%-20% vs avg
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 87/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
66.7%
-19.8% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
67% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (4)
Trial Status
Completed2
Recruiting1
Terminated1
Trial Success Rate
66.7%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07071441Not ApplicableRecruiting
Indomethacin vs Diclofenac for Preventing PEP
NCT05947461Not ApplicableTerminated
Prevention of Post-ERCP Pancreatitis by Indomethacin Vs Diclofenac
NCT06031363Not ApplicableCompleted
The Optimal Dose of Indomethacin Suppository for Preventing Post-ERCP Pancreatitis
NCT03620825Not ApplicableCompleted
The Effect of Dehydration on Intestinal Permeability
Showing all 4 trials